Related Experiment Video
Updated: Jun 16, 2026
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures
Gadi Pelled1, Ayelet Ben-Arav, Colleen Hock
1Skeletal Biotechnology Laboratory, Hebrew University of Jerusalem-Hadassah Medical Campus, Jerusalem, Israel.
Abstract:
While various problems with bone healing remain, the greatest clinical change is the absence of an effective approach to manage large segmental defects in limbs and craniofacial bones caused by trauma or cancer. Thus, nontraditional forms of medicine, such as gene therapy, have been investigated as a potential solution. The use of osteogenic genes has shown great potential in bone regeneration and fracture healing. Several methods for gene delivery to the fracture site have been described. The majority of them include a cellular component as the carrying vector, an approach known as cell-mediated gene therapy. Yet, the complexity involved with cell isolation and culture emphasizes the advantages of direct gene delivery as an alternative strategy. Here we review the various approaches of direct gene delivery for bone repair, the choice of animal models, and the various outcome measures required to evaluate the efficiency and safety of each technique. Special emphasis is given to noninvasive, quantitative, in vivo monitoring of gene expression and biodistribution in live animals. Research efforts should aim at inducing a transient, localized osteogenic gene expression within a fracture site to generate an effective therapeutic approach that would eventually lead to clinical use.
Insights
Gene therapy offers a promising solution for large bone defects. Direct gene delivery, bypassing cell carriers, is a simpler, effective strategy for bone regeneration and fracture healing.
Area of Science:
- Regenerative Medicine
- Biotechnology
- Orthopedic Surgery
Background:
- Large segmental bone defects from trauma or cancer pose significant clinical challenges.
- Current treatments lack effective solutions for regenerating extensive bone loss.
- Gene therapy, particularly using osteogenic genes, shows potential for bone repair.
Purpose of the Study:
- To review direct gene delivery methods for bone repair.
- To discuss animal models and outcome measures for evaluating gene therapy techniques.
- To emphasize noninvasive, in vivo monitoring of gene expression and biodistribution.
Main Methods:
- Review of existing literature on direct gene delivery for bone regeneration.
- Analysis of various animal models used in bone healing studies.
- Evaluation of outcome measures for assessing therapeutic efficiency and safety.
Main Results:
- Direct gene delivery presents advantages over cell-mediated gene therapy due to its simplicity.
- Noninvasive, quantitative in vivo monitoring is crucial for evaluating gene expression and biodistribution.
- Transient, localized osteogenic gene expression is a key goal for effective bone repair.
Conclusions:
- Direct gene delivery is a viable alternative for managing large bone defects.
- Further research focusing on transient, localized gene expression could lead to clinical applications.
- Standardized methods for in vivo monitoring are essential for advancing bone regeneration therapies.
More Related Videos
09:34Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
Published on: September 7, 2017
08:20A Reliable and Reproducible Critical-Sized Segmental Femoral Defect Model in Rats Stabilized with a Custom External Fixator
Published on: March 24, 2019
